GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed May 22, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-05-18$2.60/sh−21,062$54,761→ 11,165,351 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.